Alerts will be sent to your verified email
Verify Email
KAUSAMBI
|
Golden Bull Research
|
Tejassvi Aaharam
|
Rubra Medicaments
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-0.44 % | -102.32 % | -2.03 % |
|
5yr average Equity Multiplier
|
2.12 | -0.01 | 1.44 |
|
5yr Average Asset Turnover Ratio
|
0.38 | 0.48 | 1.44 |
|
5yr Avg Net Profit Margin
|
-0.27 % | 70.39 % | -0.31 % |
|
Price to Book
|
3.48 | 0.0 | 28.67 |
|
P/E
|
88.97 | 0.0 | 636.51 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 0.0 | 183.71 Days |
|
Inventory Days
|
0.0 | 0.0 | 0.0 |
|
Days Receivable
|
0.0 | 0.0 | 183.71 Days |
|
Days Payable
|
375.68 Days | 3.17 Days | 33.56 Days |
|
5yr Average Interest Coverage Ratio
|
-440.79 | 285.16 | -248.31 |
|
5yr Avg ROCE
|
-0.31 % | -191.17 % | -2.28 % |
|
5yr Avg Operating Profit Margin
|
-2.55 % | -34.75 % | -0.3 % |
|
5 yr average Debt to Equity
|
0.0 | -1.0 | 0.06 |
|
5yr CAGR Net Profit
|
-100.0 % | n/a | 0.0 |
|
5yr Average Return on Assets
|
-0.15 % | 1596.51 % | -1.63 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
1.46 % | 0.0 | 0.0 |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -0.04 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Golden Bull Research
|
Tejassvi Aaharam
|
Rubra Medicaments
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|